Clinical trial

Young Adults With Early-onset Obesity Treated With Semaglutide

NCT05574439

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-05-30

PhasePHASE4

Study timeline

Study start (actual)2022-05-30Date precision: day

Registry last updated2026-07-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesity, Adolescentunresolved

Interventions

TCOC treatmentBEHAVIORAL

Semaglutide 3 mg/mlDRUG

Placebo (Semaglutide 3 mg/ml)DRUG

Sponsors & collaborators

Signe Torekovlead sponsor

University of Leedscollaborator

Karolinska Institutetcollaborator

Holbaek Sygehuscollaborator

Copenhagen University Hospital, Rigshospitaletcollaborator

Mapped research locations

CopenhagenDenmark1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05574439 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.